EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
about
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesDe-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaOral cancer, HPV infection and evidence of sexual transmissionHPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment StrategiesAdvanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerG-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?HPV in oropharyngeal cancer: the basics to know in clinical practiceCurrent role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinomaPrimary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancerHuman papilloma virus in head and neck cancers-role and relevance in clinical managementWhat is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?Human papillomavirus and survival of patients with oropharyngeal cancer.Molecular Aspects of Head and Neck Cancer TherapyHigher micronutrient intake is associated with human papillomavirus-positive head and neck cancer: a case-only analysisThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisComprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsCurcumin induces apoptosis of upper aerodigestive tract cancer cells by targeting multiple pathwaysHuman papillomavirus-related esophageal cancer survival: A systematic review and meta-analysisManagement of Oropharyngeal Cancer in the HPV Era.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North AmericansInduction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer.Tobacco use in human papillomavirus-positive advanced oropharynx cancer patients related to increased risk of distant metastases and tumor recurrence.High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methods.Human papillomavirus, p16 and p53 expression associated with survival of head and neck cancer.Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancerRefining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse studyHIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia.Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma.Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.Prevalence and predictive role of p16 and epidermal growth factor receptor in surgically treated oropharyngeal and oral cavity cancerMeta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Clinical and scientific impact of human papillomavirus on head and neck cancer.High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.Human papillomavirus-associated oropharyngeal cancer: a new clinical entity.
P2860
Q22306233-0972760C-ABBD-431E-9D8E-9C7E3485BC9FQ24200362-11256A25-AEA3-4A41-B549-86BFB022FD57Q24617682-51310018-DDB1-4FCB-A9EE-11B86B0EA3EEQ26752584-D484DC3E-7C98-48FB-A1C8-ED0B25531DC7Q26767046-B5E3CF8C-F535-49C0-B634-B285E021094DQ26782255-8585104E-7AAE-460D-90C9-B1C48665C29BQ26801162-255A91D3-D40E-49AB-B7AF-DC42E8029F63Q26853669-1817B1F6-A6C0-43EE-AAD2-90930051A98EQ26991953-32D8A55F-564E-496C-9DE7-6FC9CD9D4B78Q27009148-6B2BF516-AC4D-477C-825D-5A338A3ACCE6Q27021230-ABE8458B-08F8-4DE8-A02C-51EF379FE194Q27026269-4F2D82D8-79BA-4FFF-BA05-7413013171C5Q27851567-AF75D9DE-C79D-4E21-BD4C-A5FEB27DC193Q28082815-A92104EE-C749-4EC2-B433-3E89A08239DFQ28386178-2A302E05-5171-4748-B79F-A473654C58B0Q28388257-FBF5E377-303C-4EE3-B266-BD0D7937BF38Q28485279-626D1C6B-901A-4546-93EB-17A19C91D0F6Q28546708-F6A4C206-05E4-4EAD-839A-1D8CCF1CF199Q30241058-74071886-A342-44EE-91BD-38AF08E50F74Q30248326-A1AEA9C6-F6F5-40AF-8233-AE1BC7B83657Q30252081-FAC5804F-2CFE-44DB-ABB8-959C2EB12026Q30373904-C8E40B87-BB35-4EFE-95C9-53DBF8102BF0Q33503791-BC566C4E-BEB1-48ED-A634-AF23737F21A0Q33561959-3F15835C-BCD3-4517-BD4F-DFA839FB71B9Q33639789-CC1E02D2-2894-4946-AF10-78A6CB21465DQ33658257-8C040653-6B99-46E9-9313-E6321BEDFBB1Q33726331-0093DE22-D6FA-41F8-BE0C-794019397492Q33736889-F5F24876-863C-41A0-B2EA-F548513B0B6BQ33756093-575D55BB-59B8-4EC7-8454-E6674EA32451Q33791902-D6707B90-A670-416C-A4FB-72FA0C9F3ACCQ33863850-E5B87AAB-939A-48B1-B35B-902D7C129DAEQ33863903-00E929C6-B963-4045-A313-384CE7612CECQ33947789-B05DA255-0702-4C91-81E3-0CBABD968DE8Q33954449-F027BDB9-99DA-4D59-8899-483DE2E9C520Q33976619-76232DC2-050D-4B35-BBE3-A3798DAC35E0Q33986942-EBBCCAC6-BE8A-482D-A8A1-360D91D866F8Q34011808-52B49E19-803A-4D33-91F3-B9904EE4FDAAQ34031281-ED0C52A8-BFEA-46D2-9CE5-9D496C5E9D47Q34041357-B40DFF52-22CE-4B2E-8873-B60EEC20E5FCQ34088512-487283A6-7BEC-45DC-AE6B-1AFD0966390E
P2860
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
EGFR, p16, HPV Titer, Bcl-xL a ...... rvival in oropharyngeal cancer
@en
EGFR, p16, HPV Titer, Bcl-xL a ...... vival in oropharyngeal cancer.
@nl
type
label
EGFR, p16, HPV Titer, Bcl-xL a ...... rvival in oropharyngeal cancer
@en
EGFR, p16, HPV Titer, Bcl-xL a ...... vival in oropharyngeal cancer.
@nl
prefLabel
EGFR, p16, HPV Titer, Bcl-xL a ...... rvival in oropharyngeal cancer
@en
EGFR, p16, HPV Titer, Bcl-xL a ...... vival in oropharyngeal cancer.
@nl
P2093
P2860
P356
P1476
EGFR, p16, HPV Titer, Bcl-xL a ...... rvival in oropharyngeal cancer
@en
P2093
Bhavna Kumar
Carol R Bradford
Christina I Tsien
David M Kurnit
Douglas B Chepeha
Francis P Worden
Gregory T Wolf
Huong H Tran
Jeremy M G Taylor
Joshua A Bauer
P2860
P304
P356
10.1200/JCO.2007.12.7662
P407
P577
2008-05-12T00:00:00Z